tiprankstipranks
Oruka Therapeutics (ORKA)
NASDAQ:ORKA
US Market

Oruka Therapeutics (ORKA) Stock News & Sentiment

Compare
609 Followers
Oruka Therapeutics Positioned for Growth with Strategic Licensing and Promising IL-17A/F Inhibitor Development
Premium
Ratings
Oruka Therapeutics Positioned for Growth with Strategic Licensing and Promising IL-17A/F Inhibitor Development
15d ago
Oruka Therapeutics: Strong Q3 and Strategic Advances
Premium
Company Announcements
Oruka Therapeutics: Strong Q3 and Strategic Advances
3M ago
Oruka Therapeutics Adjusts Executive Severance Agreements
Premium
Company Announcements
Oruka Therapeutics Adjusts Executive Severance Agreements
5M ago

News Score - Last 7 Days

Neutral
ORKA
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ORKA’s Media Buzz Sentiment?
1 articles about ORKA were published this week. In an average week, 1 articles are published.
    What is ORKA’s weekly average amount of articles?
    In an average week, 1 articles about ORKA are published.
      What is ORKA’s News Sentiment?
      50% of articles about ORKA were positive this week, compared to its sector average of 57%.
        Healthcare Stocks that are Trending in the News
        SHGSingular Health Group Ltd
        RCUSArcus Biosciences
        HCMHUTCHMED
        PENPenumbra
        AMNAMN Healthcare Services
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis